21. Yüzyılda polimyaljiya romatika

YAĞCI, İlker

21. Yüzyılda polimyaljiya romatika

İlker YAĞCI (Marmara Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, İstanbul, Türkiye)

Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi

0 0

Yıl: 2012 Cilt: 58 Sayı: 2 Sayfa Aralığı: 143 - 150 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

21. Yüzyılda polimyaljiya romatika

Öz:

Polimyaljiya romatika (PMR), ileri yaş grubunda omuz ve pelvik kuşak ağrısı ve sabah tutukluğu ile karakterize inflamatuvar bir hastalıktır. Hastalığın etiyopatogenezi tam olarak bilinmemekle birlikte genetik ve çevresel faktörler suçlanmaktadır. Tanı için özgül bir test bulunmamakta, görüntüleme yöntemlerindeki gelişmelere rağmen tanı klinik bulgulara dayanmaktadır. Tedavisinde steroidler başlıca kullanılan ilaçlardır, hatta steroide verilen dramatik yanıt tanı kriteri olarak kullanılmıştır. Buna karşın steroidin başlangıç dozu, kullanım süresi, doz azaltılması konularında optimal bir yaklaşım söz konusu değildir. Dahası steroid tedavisi altında relapslar izlenebilmektedir. Steroidlerin etkisiz olduğu durumlarda veya steroidler kesilmek istendiğinde metotreksat kullanılabilmektedir. Son yıllarda biyolojik ajanların kullanılması ile ilgili deneyim artmaktadır.

Anahtar Kelime:

Konular: Rehabilitasyon

Polymyalgia rheumatica in 21st century

Öz:

Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease of elderly, characterised by pain and morning stiffness of the shoulder and pelvic girdle. Although the ethiopathogenesis of PMR is unknown, environmental and genetic factors are suspected. Despite the progress in imaging techniques achieved in recent years, there is no speific diagnostic test and the diagnosis is generally based on clinical features. The steroids are the main therapy for PRM. Thus, the dramatic response to steroid therapy has been used as a diagnostic criterion. However, there is lack of optimal intervention regarding initial dose, usage period and dose reduction. Moreover, relapses can be seen during the steroid therapy. Methotrexate can be used in case of unresponsiveness to steroids or aim to reduce daily steroid dose. The experiences about using biologic agents are increasing in recent years.

Anahtar Kelime:

Konular: Rehabilitasyon

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Hunder GG. The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970. Mayo Clin Proc 2006;81:1071-83.
2. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004;33:289-93.
3. Salvarani C, Gabriel SE, OFallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-73.
4. Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J of Rheumatology 1995;34:261-4.
5. Okumura T, Tanno S, Ohhira M, Nozu T. The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan. Rheumatol Int. 2011 Mar 24. [Epub ahead of print]
6. Soriano A, Landolfi R, Manna R. Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol 2012;26:91-104.
7. Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 2009;27:830-3.
8. Aydeniz A, Altındağ O, Öğüt E, Gürsoy S. Late onset spondyloarthropathy mimicking polymyalgia rheumatica. Rheumatol Int 2012;32:1357-8.
9. Liozon E, Ouattara B, Rhaiem K, Ly K, Bezanahary H, Loustaud V et al. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families. Clin Exp Rheumatol 2009;27(1 Suppl 52):89-94.
10. Bartolome MJ, Martínez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis. Clin Exp Rheumatol 2001;19:259-64.
11. Perfetto F, Moggi-Pignone A, Becucci A, Cantini F, Di Natale M, Livi R, et al. Seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 2005;64:1662-3.
12. Peris P. Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection. J Rheumatol 2003;30:2624-6.
13. Soriano A, Verrecchia E, Marinaro A, Giovinale M, Fonnesu C, Landolfi R, et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 2012;21:153-7.
14. Alvarez-Rodríguez L, Lopez-Hoyos M, Mata C, Marin MJ, Calvo-Alen J, Blanco R, et al. Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis 2010;69:263-9.
15. Straub RH, Glück T, Cutolo M, Georgi J, Helmke K, Schölmerich J, et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology 2000;39:624-31.
16. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
17. Uddhammar A, Sundqvist KG, Ellis B, Rantapää-Dahlqvist S. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol 1998;37:766-9.
18. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008;371:987-97.
19. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F et al. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 2006;33:703-8.
20. Kreiner F, Galbo H. Insulin sensitivity and related cytokines,chemokines and adipokines in polymyalgia rheumatica. Scand J Rheumatol 2010;39:402-8. E-pub ahead of print.
21. Kreiner F, Langberg H, Galbo H. Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis Rheum 2010;62:3768-75.
22. Straub RH, Herfarth HH, Rinkes B, Konecna L, Gluck T, von Landerberg P, et al. Favorable role of interleukin 10 in patients with polymyalgia rheumatica. The Journal of Rheumatology 1999;26:1318-25.
23. Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C et al. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012;64:943-54.
24. Bahlas S, Ramos-Remus C, Davis P. Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians. Clin Rheumatol 2000;19:278-80.
25. Shimojima Y, Matsuda M, Ishii W, Gono T, Ikeda S. Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis. Clin Exp Rheumatol 2008;26:1079-82.
26. Oide T, Ohara S, Oguchi K, Maruyama M, Yazawa M, Inoue K, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients. Clin Exp Rheumatol 2004;22:91-8.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
28. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
29. Cantini F, Salvarani C, Olivieri I, Niccoli L, Macchioni P, Boiardi L, et al. Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis Rheum 2001;44:1155-9.
30. Ceccato F, Roverano S, Barrionuevo A, Rillo O, Paira S. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol 2006;25:854-7.
31. Falsetti P, Acciai C, Volpe A, Lenzi L. Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome? Scand J Rheumatol 2011;40:57-63.
32. Pease CT, Haugeberg G, Morgan AW, Montague B, Hensor EM, Bhakta BB. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation. J Rheumatol 2005;32:1043-6.
33. Pease CT, Haugeberg G, Montague B, Hensor EM, Bhakta BB, Thomson W et al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford) 2009;48:123-7.
34. Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgiarheum atica/giant cell arteritis syndrome. Ann Rheum Dis 1983;42:168-70.
35. Camellino D, Cimmino MA. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford) 2012;51:77-86.
36. Cantini F, Salvarani C, Olivieri I, Niccoli L, Padula A, Macchioni L, et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. The Journal of Rheumatology 2001;28:1049-55.
37. Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiardi L, et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clinical and Experimental Rheumatology 2005;23:462-8.
38. Mori S, Koga Y, Ito K. Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging. Mod Rheumatol 2007;17:369-75.
39. Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C. Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) 2009;48:1566-9.
40. Rozin AP. US imaging of shoulder fasciitis due to polymyalgia rheumatica. Neth J Med 2008;66:88.
41. Jiménez-Palop M, Naredo E, Humbrado L, Medina J, Uson J, Francisco F, et al. Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica. Ann Rheum Dis 2010;69:879-82.
42. Cimmino MA, Parodi M, Zampogna G, Barbieri F, Garlaschi G. Polymyalgia rheumatica is associated with extensor tendon tenosynovitis but not with synovitis of the hands: a magnetic resonance imaging study. Rheumatology (Oxford) 2011;50:494-9.
43. McGonagle D, Pease C, Marzo-Ortega H, O'Connor P, Gibbon W, Emery P. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 2001;28:1837-41.
44. Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, et al Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008;67:758-61.
45. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000;108:246-9.
46. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 2007;46:672-7.
47. Bird HA, EsselinckxW, Dixon AS, Mowat AG,Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
48. Chuang TY, Hunder GG, Ilstrup DM, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Annof Int Med 1982;97:672-80.
49. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semi Arthritis Rheum 1984;13:322-8.
50. Barraclough K, Liddell WG, du Toit J, Foy C, Dasgupta B, Thomas M, et al. Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome. Fam Pract 2008;25:328-33.
51. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, et al. International Work Group for PMR and GCA. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis 2011;70:447-53.
52. Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, et al. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). Ann Rheum Dis 2003;62:1189-94.
53. Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol 2012;39:310-3.
54. Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission. Arthritis Rheum 2007;57:810-5.
55. Binard A, de Bandt M, Berthelot JM, Saraux A; Inflammatory Joint Disease Working Group of the French Society for Rheumatology. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Arthritis Rheum 2008;59:263-9.
56. Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford) 2010;49:1158-63.
57. Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 2002;29:2143-7.
58. Ornetti P, Guillibert-Karras C, Garrot JF, Gros F, Gérard N, Julien L, et al. Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica. Clin Rheumatol 2011;30:51-6.
59. Cimmino MA, Parodi M, Montecucco C, Caporali R. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 2011;12:94.
60. Gonzalez-Gay MA, Agudo M, Martinez-Dubois C, Pompei O, Blanco R. Medical management of polymyalgia rheumatica. Expert Opin Pharmacother 2010;11:1077-87.
61. Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis 2009;68:1833-8.
62. Mazzantini M, Torre C, Miccoli M, Baggiani A, Talarico R, Bombardieri S, et al. Adverse Events During Longterm Low-dose Glucocorticoid Treatment of Polymyalgia Rheumatica: A Retrospective Study. J Rheumatol 2012;39:552-7.
63. Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM 3rd, Hunder GG, Gabriel SE. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007;57:279-86.
64. Pulsatelli L, Dolzani P, Silvestri T, Boiardi L, Salvarani C, Macchioni P, et al. Circulating RANKL/OPG in polymyalgia rheumatica. Clin Exp Rheumatol 2007;25:621-3.
65. Barnes TC, Daroszewska A, Fraser WD, Bucknall RC. Bone turnover in untreated polymyalgia rheumatica. Rheumatology (Oxford) 2004;43:486-90.
66. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004;141:493-500.
67. Cimmino MA, Salvarani C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C, et al. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol 2008;26:395-400.
68. Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 2007;146:631-9.
69. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis. A randomized trial. Ann Intern Med 2007;146:621-630.
70. Kreiner F, Galbo H. Effect of etanercept in polymyalgia rheumatica: arandomized controlled trial. Arthritis Res Ther 2010;12:176.
71. Corrao S, Pistone G, Scaglione R, Colomba D, Calvo L, Licata G. Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study. Clin Rheumatol 2009;28:89-92.
72. Catanoso MG, Macchioni P, Boiardi L, Pipitone N, Salvarani C. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study. Arthritis Rheum 2007;57:1514-9.
73. Hagihara K, Kawase I, Tanaka T, Kishimoto T. Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica. J Rheumatol 2010;37:1075-6.

APA	YAĞCI İ (2012). 21. Yüzyılda polimyaljiya romatika. , 143 - 150.
Chicago	YAĞCI İlker 21. Yüzyılda polimyaljiya romatika. (2012): 143 - 150.
MLA	YAĞCI İlker 21. Yüzyılda polimyaljiya romatika. , 2012, ss.143 - 150.
AMA	YAĞCI İ 21. Yüzyılda polimyaljiya romatika. . 2012; 143 - 150.
Vancouver	YAĞCI İ 21. Yüzyılda polimyaljiya romatika. . 2012; 143 - 150.
IEEE	YAĞCI İ "21. Yüzyılda polimyaljiya romatika." , ss.143 - 150, 2012.
ISNAD	YAĞCI, İlker. "21. Yüzyılda polimyaljiya romatika". (2012), 143-150.

APA	YAĞCI İ (2012). 21. Yüzyılda polimyaljiya romatika. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 58(2), 143 - 150.
Chicago	YAĞCI İlker 21. Yüzyılda polimyaljiya romatika. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 58, no.2 (2012): 143 - 150.
MLA	YAĞCI İlker 21. Yüzyılda polimyaljiya romatika. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, vol.58, no.2, 2012, ss.143 - 150.
AMA	YAĞCI İ 21. Yüzyılda polimyaljiya romatika. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2012; 58(2): 143 - 150.
Vancouver	YAĞCI İ 21. Yüzyılda polimyaljiya romatika. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2012; 58(2): 143 - 150.
IEEE	YAĞCI İ "21. Yüzyılda polimyaljiya romatika." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 58, ss.143 - 150, 2012.
ISNAD	YAĞCI, İlker. "21. Yüzyılda polimyaljiya romatika". Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 58/2 (2012), 143-150.